ReviewTrends in molecular medicine2018

A New Class of Antiretroviral Enabling Innate Immunity by Protecting APOBEC3 from HIV Vif-Dependent Degradation.

Ryan P Bennett et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.